12 Marijuana Stocks to Buy Now in 2018

Share on StockTwits

There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.

Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.

This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.

#1 - Canopy Growth (CVE:CGC)

MarketBeat Followers: 1,443
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Canopy Growth logoCanopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.

#2 - Canopy Growth (TSE:WEED)

MarketBeat Followers: 1,226
Market Cap: C$6.35 billion
Consensus Rating: Buy
Rating Score: 2.7
Ratings Breakdown: 1 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: C$27.13 (-3.9% Upside)

Canopy Growth logoCanopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

#3 - Terra Tech (OTCMKTS:TRTC)

MarketBeat Followers: 945
Market Cap: $205.76 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Terra Tech logoTerra Tech Corp. is a cannabis-focused agriculture company. The Company operates through two segments: Hydroponic Produce and Cannabis Products. The Company, through its subsidiary, GrowOp Technology Ltd., is engaged in the design, marketing and sale of hydroponic equipment. It is also a retail seller of locally grown hydroponic produce, herbs, and floral products through its subsidiary, Edible Garden Corp. (Edible Garden). It intends to operate medical marijuana cultivation, production and dispensary facilities in Nevada through its subsidiaries, MediFarm, LLC (MediFarm), MediFarm I, LLC (MediFarm I) and MediFarm II, LLC (MediFarm II). Through its subsidiary, IVXX, Inc. (IVXX), it produces and sells a line of cannabis flowers and cigarettes, among others. The hydroponic produce segment consists of Edible Garden's business and operations. Its cannabis products segment consists of IVXX's business, as well as the proposed business operations of MediFarm, MediFarm I and MediFarm II.

#4 - 22nd Century Group (NYSEAMERICAN:XXII)

MarketBeat Followers: 714
Market Cap: $316.82 million
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $11.50 (461.0% Upside)

22nd Century Group logo22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. The company's products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation; and modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than conventional tobacco cigarettes, as well as BRAND B cigarettes that contain low amount of tar per milligram of nicotine. 22nd Century Group, Inc. has a scientific collaboration with the University of Virginia; and a strategic partnership with Anandia Laboratories, Inc. The company was founded in 1998 and is headquartered in Clarence, New York.

#5 - Cannabis Science (OTCMKTS:CBIS)

MarketBeat Followers: 692
Market Cap: $190.59 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Cannabis Science logoCannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

#6 - OrganiGram (CVE:OGI)

MarketBeat Followers: 574
Market Cap: C$536.91 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: C$6.25 (59.0% Upside)

OrganiGram logoOrganiGram Holdings Inc., through its subsidiaries, produces and sells medical marijuana to individuals and physicians in Canada. It offers marijuana plants, seeds, and cuttings; cannabis oil; and dried flower and cannabis. The company sells its products through phone and online store. It also operates healing centers that offer treatments for post-traumatic stress disorders, chronic pain, and trauma therapy. OrganiGram Holdings Inc. was founded in 2013 and is based in Moncton, Canada.

#7 - United Cannabis (OTCMKTS:CNAB)

MarketBeat Followers: 389
Market Cap: $67.44 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

United Cannabis logoUnited Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. United Cannabis Corporation has strategic partnerships with WeedMD RX Inc. to grow, produce, and sell medical marijuana; and has an agreement with Cherubim Interests, Inc. The company was formerly known as MySkin, Inc. and changed its name to United Cannabis Corporation in May 2014. United Cannabis Corporation was founded in 2007 and is based in Denver, Colorado.

#8 - Cannabis Sativa (OTCMKTS:CBDS)

MarketBeat Followers: 351
Market Cap: $100.69 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Cannabis Sativa logoCannabis Sativa, Inc., through its subsidiaries, develops, manufactures, and sells herbal based skin care products in the United States. It offers Recover, a deep penetrating healing balm that reduces pain and inflammation for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant and moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also engages in the research, development, and licensing of natural cannabis products comprising cannabis formulations, edibles, topicals, strains, recipes, and delivery systems. In addition, it operates iBudtender, an online portal that offers information and patient reviews on marijuana dispensaries, cannabis businesses, marijuana strains, edibles, and concentrates and products. The company markets and sells its products through sales professionals, as well as through retailers and distributors. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

#9 - Medical Marijuana (OTCMKTS:MJNA)

MarketBeat Followers: 295
Market Cap: $325.25 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Medical Marijuana logoMedical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California.

#10 - MassRoots (OTCMKTS:MSRT)

MarketBeat Followers: 247
Market Cap: $41.56 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

MassRoots, Inc., together with its subsidiaries, operates a technology platform for the medical cannabis community in the United States. Its platform enables users to share their cannabis content, follow various dispensaries, and stay connected with the legalization movement; and its mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. The company's network is accessible as a free mobile application through the iOS App Store, the Amazon App Store, and the Google Play Marketplace, as well as a Website at MassRoots.com. It also operates MassRoots for Business, an online portal for businesses to schedule posts and view analytics, as well as sells merchandise, including T-shirts, stickers, and jars. In addition, the company engages in developing Blockchain-based solutions for the cannabis industry. MassRoots, Inc. was founded in 2013 and is headquartered in Denver, Colorado.

#11 - General Cannabis (OTCMKTS:CANN)

MarketBeat Followers: 242
Market Cap: $148.11 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

General Cannabis Corp. provides services to the regulated cannabis industry in the United States. The company engages in the acquisition and leasing of cultivation space and related facilities to licensed marijuana growers and dispensary owners; and provision of security services, including on-site professionals, video surveillance, and cash transport to licensed cannabis cultivators and retail shops. It also designs, distributes, and sells apparel featuring graphic designs; designs and sources client-specific apparel and products; and offers consulting services to the cannabis industry that comprise obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design, and construction services. In addition, General Cannabis Corp. provides shared office space, networking, and event services; and provides direct term loans and revolving lines of credit to businesses involved in the cultivation and sale of cannabis and related products. The company was formerly known as Advanced Cannabis Solutions, Inc. and changed its name to General Cannabis Corp. in June 2015. General Cannabis Corp. was founded in 2013 and is headquartered in Denver, Colorado.

#12 - Marijuana Co of America (OTCMKTS:MCOA)

MarketBeat Followers: 224
Market Cap: $58.27 million
Consensus Rating: N/A
Rating Score: NaN
Ratings Breakdown: 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: N/A

Marijuana Company of America, Inc., a cannabis and hemp company, engages in the marketing, sale, and delivery of medical marijuana in the United States and internationally. The company offers hemp-based solutions for health and beauty, and a range of accessories and clothing derived from hemp under the HempSmart brand name. It also offers its products through hempSMART.com. The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was founded in 1985 and is based in Escondido, California.







More on MarketBeat
12 Cheap Dividend Stocks to Buy Today12 Cheap Dividend Stocks to Buy Today
12 Stocks Corporate Insiders are Abandoning12 Stocks Corporate Insiders are Abandoning
7 Best Stocks to Own Right Now7 Best Stocks to Own Right Now
Top Ten Brokerages You Can TrustTop Ten Brokerages You Can Trust
Analysts Hate These 12 StocksAnalysts Hate These 12 Stocks
10 Great Cheap Stocks to Buy Now for Under $1010 Great Cheap Stocks to Buy Now for Under $10
10 Rock-Solid Dividend Paying Stocks to Own in 201810 Rock-Solid Dividend Paying Stocks to Own in 2018


Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.